Evaluation of solubility and partition properties of ampicillin-based ionic liquids

In order to overcome the problems associated with low water solubility, and consequently low bioavailability of active pharmaceutical ingredients (APIs), herein we explore a modular ionic liquid synthetic strategy for improved APIs. Ionic liquids containing l-ampicillin as active pharmaceutical ingr...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics Vol. 456; no. 2; pp. 553 - 559
Main Authors: Florindo, Catarina, Araújo, João M.M., Alves, Filipa, Matos, Carla, Ferraz, Ricardo, Prudêncio, Cristina, Noronha, João Paulo, Petrovski, Željko, Branco, Luís, Rebelo, Luís Paulo N., Marrucho, Isabel M.
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 18-11-2013
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In order to overcome the problems associated with low water solubility, and consequently low bioavailability of active pharmaceutical ingredients (APIs), herein we explore a modular ionic liquid synthetic strategy for improved APIs. Ionic liquids containing l-ampicillin as active pharmaceutical ingredient anion were prepared using the methodology developed in our previous work, using organic cations selected from substituted ammonium, phosphonium, pyridinium and methylimidazolium salts, with the intent of enhancing the solubility and bioavailability of l-ampicillin forms. In order to evaluate important properties of the synthesized API-ILs, the water solubility at 25°C and 37°C (body temperature) as well as octanol–water partition coefficients (Kow's) and HDPC micelles partition at 25°C were measured. Critical micelle concentrations (CMC's) in water at 25°C and 37°C of the pharmaceutical ionic liquids bearing cations with surfactant properties were also determined from ionic conductivity measurements.
Bibliography:http://dx.doi.org/10.1016/j.ijpharm.2013.08.010
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0378-5173
1873-3476
DOI:10.1016/j.ijpharm.2013.08.010